Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arterial Vascular Engineering AVEI -- Ignore unavailable to you. Want to Upgrade?

To: jbershad who wrote (69)	3/6/1998 2:13:00 PM
From: Platter	Read Replies (1) \| Respond to of 410

Insiders at Arterial Vascular Sold Stock When Price Surged By Laura Saunders Egodigwe Summary: Seven officers and directors sold around 1.3 million shares valued at 71.3 million from Jan 8 to Feb 2 at $53.00 - $72.00 per share. Company officials couldn't be reached to comment. "The amount of selling increased rather dramatically as shares rose, and some of the insiders trimmed significant amounts from their holdings", says Bob Gabele, president of CDA/Investnet. "Their expectations may not be as high as those of some who are bidding the stock up".